Ocular Hypotensive Efficacy and Safety of the Rho Kinase Inhibitor AR-12286 in Patients With Elevated Intraocular Pressure

被引：0
|
作者：
Williams, R. D. [1 ]
Novack, G. D. [2 ]
van Haarlem, T. [3 ]
Kopczynski, C. [4 ]
机构：
[1] Clin Res Ctr, Louisville, KY USA
[2] PharmaLog Dev Inc, San Rafael, CA USA
[3] Aerie Pharmaceut Inc, Bridgewater, NJ USA
[4] Aerie Pharmaceut Inc, Res Triangle Pk, NC USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
intraocular pressure; trabecular meshwork; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1633
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ocular hypotensive efficacy and safety of a fixed dose combination of AR-12286 (a Rho Kinase Inhibitor) and travoprost
    Levy, Brian
    Lewis, Richard
    Kopczynski, Casey
    Van Haarlem, Thomas
    Novack, Gary
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension
    Williams, Robert D.
    Novack, Gary D.
    van Haarlem, Thomas
    Kopczynski, Casey
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 152 (05) : 834 - 841
  • [3] Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
    Skaat, Alon
    Jasien, Jessica V.
    Ritch, Robert
    JOURNAL OF GLAUCOMA, 2016, 25 (09) : E807 - E814
  • [4] Ocular hypotensive efficacy, safety and systemic absorption of AR-12286 ophthalmic solution in normal volunteers
    Kopczynski, Casey
    Novack, Gary D.
    Swearingen, Dennis
    van Haarlem, Thomas
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (05) : 567 - 572
  • [5] Rho Kinase Inhibitor AR-12286 Reverses Steroid-induced Changes in Mouse Eyes
    Ren, Ruiyi
    Humphrey, Anne A.
    Kopczynski, Casey
    Gong, Haiyan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [6] Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes
    Ren, Ruiyi
    Humphrey, Anne A.
    Kopczynski, Casey
    Gong, Haiyan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (02)
  • [7] Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% Efficacy in Patients with Exfoliation Syndrome (XFS) and Ocular Hypertension (OHT) or Exfoliative Glaucoma (XFG)
    Jasien, Jessica V.
    Skaat, Alon
    Ritch, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [8] Discovery and in vitro SAR of AR-12286, a potent kinase inhibitor for the treatment of glaucoma
    deLong, Mitchell A.
    Sturdivant, J. M.
    Royalty, S. M.
    Heintzelman, G. R.
    Yingling, J. D.
    Laethem, C. L.
    Sherman, B. W.
    Kopczynski, C. C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [9] The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
    Pakravan, Mohammad
    Beni, Afsaneh Naderi
    Ghahari, Elham
    Varshochian, Reyhaneh
    Yazdani, Shahin
    Esfandiari, Hamed
    Ahmadieh, Hamid
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (06) : e676 - e680
  • [10] Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
    Wu, Jo-Hsuan
    Chang, Sheng-Nan
    Nishida, Takashi
    Kuo, Bo-, I
    Lin, Jou-Wei
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (03) : 937 - 948
12345